The common problem of rare disease in general practice

Area of Science:

• Public Health
• General Practice
• Rare Diseases

Background:

• Rare diseases impact 6%-10% of the global population, with approximately 1.2 million individuals in Australia affected.
• While other nations have established coordinated policies and patient advocacy for rare diseases, Australia's approach remains fragmented.
• General practitioners (GPs) frequently encounter patients with rare diseases, yet their specific role in managing this population is not well-defined.

Purpose of the Study:

• To highlight the need for a coordinated approach to rare disease management in Australia.
• To emphasize the significant, yet underexplored, role of general practice in addressing the needs of rare disease patients.
• To advocate for the development of a generic general practice strategy to enhance care for individuals with rare diseases.

Main Methods:

• This study is a review of the current landscape of rare disease management in Australia.
• It analyzes the experiences of people with rare diseases and their families.
• It considers the position of general practitioners in providing care.

Main Results:

• Despite having orphan drug legislation, Australia lacks coordinated government and patient group strategies for rare diseases.
• People with rare diseases share common challenges irrespective of their specific diagnosis.
• GPs are strategically positioned to address these shared challenges.

Conclusions:

• A unified, generic general practice strategy is needed to improve the care of rare disease patients in Australia.
• Enhanced support and recognition of the GP's role can lead to better health outcomes for this vulnerable population.
• International models of coordinated rare disease policies offer valuable insights for Australia.